Schlegel S, Schlösser R, Hiemke C, Nickel O, Bockisch A, Hahn K
Department of Psychiatry, University of Mainz, Germany.
Psychopharmacology (Berl). 1996 Apr;124(3):285-7. doi: 10.1007/BF02246671.
By the application of 123([123I]IBZM), an iodine-labelled dopamine D2-receptor antagonist, brain D2 receptors in humans can be visualized with single photon emission computed tomography (SPECT). The ratio of IBZM binding to striatal regions versus binding to frontal cortex (ST/FC ratio) provided a semiquantitative measurement of D2 receptor binding in the striatum. This study investigated the relationship between receptor occupancy and plasma prolactin levels in 12 male patients treated with haloperidol, benperidol or clozapine. Prolactin levels were positively correlated with D2 receptor occupancy, reflecting at least in part a comparable dopamine receptor antagonism in different dopaminergic pathways.
通过应用123([123I]碘苄酰胺),一种碘标记的多巴胺D2受体拮抗剂,人类大脑中的D2受体可用单光子发射计算机断层扫描(SPECT)进行可视化。碘苄酰胺与纹状体区域结合与与额叶皮质结合的比率(ST/FC比率)提供了纹状体中D2受体结合的半定量测量。本研究调查了12名接受氟哌啶醇、苄哌利多或氯氮平治疗的男性患者中受体占有率与血浆催乳素水平之间的关系。催乳素水平与D2受体占有率呈正相关,这至少部分反映了不同多巴胺能途径中类似的多巴胺受体拮抗作用。